clinical trial · NCT05768269
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
Hematological MalignancySolid Tumor MalignancyNo Intervention
brief summary
This study is designed to collect long-term safety and survival data from participants previously treated in an eligible Century-sponsored index trial. This is an observational study, and the elements of the study design allow for important follow-up for safety, survival, and the continued evaluation of any late adverse events (AEs) that may appear after treatment with such cellular products. Additionally, collection of persistence data from participants will support the identification of any long-term risks or late AEs that may be causally related to treatment with such cellular products.
started
Apr 29, 2024
primary completion
Mar 1, 2040
completion
Mar 1, 2040
last updated
Jun 25, 2025
official title
A Long-Term Follow-up Study for Subjects Previously Treated With A Century Therapeutics Cellular Therapy Product
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol